Development
Core Scientific, Inc.
CORZ
$12.19
$0.262.18%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 29.76M | 29.85M | 29.83M | 22.63M | 46.79M |
| Total Other Revenue | 112.17M | 83.06M | 97.08M | 98.03M | 74.46M |
| Total Revenue | 141.93M | 112.90M | 126.91M | 120.66M | 121.25M |
| Cost of Revenue | 102.63M | 97.49M | 89.95M | 88.87M | 168.49M |
| Gross Profit | 39.30M | 15.42M | 36.96M | 31.78M | -47.24M |
| SG&A Expenses | 28.12M | 24.55M | 25.48M | 22.77M | 38.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 7.00K | 318.00K | 196.00K | -8.00K | -160.00K |
| Total Operating Expenses | 132.64M | 124.61M | 117.27M | 113.05M | 209.65M |
| Operating Income | 9.29M | -11.70M | 9.64M | 7.60M | -88.40M |
| Income Before Tax | -195.36M | -41.03M | -9.13M | -284.00K | -456.34M |
| Income Tax Expenses | 336.00K | 114.00K | 129.00K | 104.00K | -21.49M |
| Earnings from Continuing Operations | -195.69M | -41.15M | -9.26M | -388.00K | -434.85M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -195.69M | -41.15M | -9.26M | -388.00K | -434.85M |
| EBIT | 9.29M | -11.70M | 9.64M | 7.60M | -88.40M |
| EBITDA | 40.50M | 12.53M | 30.12M | 27.70M | -19.68M |
| EPS Basic | -0.51 | -0.11 | -0.02 | 0.00 | -1.07 |
| Normalized Basic EPS | -0.13 | -0.02 | 0.02 | 0.02 | -0.17 |
| EPS Diluted | -0.51 | -0.11 | -0.02 | -0.01 | -1.07 |
| Normalized Diluted EPS | -0.13 | -0.02 | 0.02 | 0.02 | -0.17 |
| Average Basic Shares Outstanding | 385.13M | 382.48M | 375.78M | 375.97M | 408.08M |
| Average Diluted Shares Outstanding | 385.13M | 382.48M | 375.78M | 375.97M | 408.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |